The CAPRISA Clinical Trials: HIV Treatment and Prevention
These studies investigated the impact of tenofovir gel as topical antiretroviral pre-exposure prophylaxis (PrEP), implementation of topical PrEP through family planning clinics, conditional cash incentives for HIV prevention, HIV vaccines, and passive immunisation with broadly neutralising antibodie...
| Other Authors: | , , |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Cham
Springer International Publishing
2017, 2017
|
| Edition: | 1st ed. 2017 |
| Subjects: | |
| Online Access: | |
| Collection: | Springer eBooks 2005- - Collection details see MPG.ReNa |
Table of Contents:
- Part I. Introduction
- Studies Linked to the Evolving HIV Epidemic in South Africa: Informing the CAPRISA Scientific Agenda
- CAPRISA: Establishing A Research Center to Undertake HIV Clinical Trials
- Overview of Clinical Trials
- Part II. CAPRISA Clinical Trials for HIV and HSV-2 Prevention
- Antiretrovirals for HIV Prevention
- Rolling out of tenofovir gel in family planning clinics: the CAPRISA 008 implementation trial
- Conditional cash transfers to reduce HIV risk in young women: the CAPRISA 007 cluster randomised control trial
- HIV vaccine and passive immunity trials
- Part III: CAPRISA Clinical Trials for HIV–TB Treatment
- CAPRISA 003: Timing of antiretroviral initiation in HIV-TB co-infected patients - The SAPiT Trial
- Scaling up TB-HIV integration in public health clinics: translating research findings into practice
- Part IV: Experiences and lessons learnt from clinical trials in CAPRISA
- Lessons from the Acute Infection Study: from Bench to Bedside
- Understanding sexual HIV transmission in women by focusing on the genital mucosa
- Part V: Essential support activities for the conduct of clinical trials
- Good practices in conducting clinical trials: Good Participatory Practice, Good Pharmacy Practice and Good Laboratory Practice
- Grants Management
- Taking science to the people: communication and media strategies for clinical trials
- Looking ahead: What Does the Future Hold for CAPRISA?
- Appendix
- Index.